Using three independent mouse models, including one hybrid (hy) angiotensin-converting enzyme 2 (ACE2) knock-in mouse model generated ad hoc for this study, we show here that prior infection or mRNA vaccination can indeed offer protection against heterologous SARS-CoV-2 challenge, all while circumventing the need for antibodies. This evidence concerns the gene ACE2 and infection.